跳至主要内容
临床试验/ISRCTN56383373
ISRCTN56383373进行中(未招募)Unknown

Surveillance of Cervical Intraepithelial Neoplasia (CIN) grade 2 with Dual P16/Ki-67 Immunocytochemistry staining

Papageorgiou General Hospital0 个研究点目标入组 100 人开始时间: 2023年10月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1. Women referred to the Unit of Colposcopy and Cervical Pathology, Department of Gynaecological Oncology, 1st Department of Obstetrics and Gynaecology, Papageorgiou” General Hospital, Thessaloniki, Greece.
  • 2. Reason for referral:
  • 2.1. Abnormal pap test (ASCUS or worse)
  • 2.2. hrHPV positivity in cervical samples
  • 2.3. Histologic diagnosis of CIN 1 or 2
  • 3. Of these women those with a final diagnosis of CIN2, who do not wish to be subjected to excision cervical procedure, are eligible to be included in the analysis.
  • 4. Age range: 21-65 years old

排除标准

  • 1. Pregnancy
  • 2. Inability to adequately communicate
  • 3. Inability to comply with the required follow-up during the study
  • 4. Recurrent or acute vaginitis
  • 5. Taking systemic immunosuppressive or immunomodulatory treatment (methotrexate, glucocorticoids, non-steroidal anti-inflammatory drugs, etc.)
  • 8. Chemotherapy
  • 9. Radiotherapy

研究者

发起方
Papageorgiou General Hospital

相似试验